Figure 4From: Meta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymes Receiver operating characteristic (ROC) curves for discrimination between localised prostate cancer and benign cases, metastatic and benign cases and metastatic and prostate cancers using a 31-gene signature (row 1), AR (row 2), ERG (row 3) and KLK3 (row 4). Back to article page